Biotech startups that raised Series A
Source: FundingWatcher. Data as of 4 September 2026.
2,362
Companies
$48.9B
Last round total
100
Rows shown
4 September 2026
Data as of
Latest rounds
Most recent round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Xianyan Biopharma | Series A | $21.8M | 2026-08-31 | Chengdu | Biotech |
| 2 | ABLE Labs | Series A | $8.8M | 2026-08-31 | Incheon | Biotech |
| 3 | Hepo Biotechnology | Series A | 2026-08-28 | Shanghai | Biotech | |
| 4 | Adaptyv Biosystems | Series A | $40.0M | 2026-08-25 | Lausanne | Biotech |
| 5 | Anda Biopharma | Series A | 2026-08-24 | Shenzhen | Artificial intelligence | |
| 6 | Fibrolink Biotech | Series A | $1.5M | 2026-08-21 | Guangzhou | Biotech |
| 7 | SiranBio | Series A | $59.5M | 2026-08-20 | Suzhou | Biotech |
| 8 | Kynexis | Series A | $112.3M | 2026-08-19 | Naarden | Biotech |
| 9 | Enginprime Medical | Series A | $12.0M | 2026-08-17 | Shanghai | Biotech |
| 10 | Errui Xinyue | Series A | $14.3M | 2026-08-13 | Daxing | Biotech |
| 11 | Remepy | Series A | $36.0M | 2026-08-12 | Ramat Gan | Biotech |
| 12 | Paterna Biosciences | Series A | $6.3M | 2026-08-12 | Salt Lake City | Biotech |
| 13 | Infinimmune | Series A | $75.0M | 2026-08-11 | Alameda | Artificial intelligence |
| 14 | Omega Ophthalmics | Series A | $7.0M | 2026-08-11 | Lexington | Biotech |
| 15 | Remedium Bio | Series A | $10.0M | 2026-08-10 | Needham | Biotech |
| 16 | ClonOrgan | Series A | 2026-08-07 | Chengdu | Biotech | |
| 17 | Phil Rivers Technology | Series A | $29.6M | 2026-08-05 | Beijing | Artificial intelligence |
| 18 | Dash Bio | Series A | $30.0M | 2026-08-03 | Boston | Artificial intelligence |
| 19 | Protoga | Series A | $14.8M | 2026-08-03 | Shenzhen | Biotech |
| 20 | Algen Biotechnologies | Series A | $12.5M | 2026-08-03 | San Francisco | Artificial intelligence |
| 21 | Beyond Therapeutics | Series A | $29.6M | 2026-07-30 | Shanghai | Biotech |
| 22 | Yuantian Bio | Series A | $14.8M | 2026-07-30 | Tianjin | Biotech |
| 23 | Genta Kyushu Bio | Series A | $14.8M | 2026-07-30 | Beijing | Biotech |
| 24 | Trace Biosciences | Series A | $8.3M | 2026-07-29 | Beaverton | Biotech |
| 25 | CORE Biomedicine | Series A | $21.0M | 2026-07-28 | Allston | Biotech |
| 26 | GOLGENIA | Series A | $1.7M | 2026-07-28 | Milano | Biotech |
| 27 | NewLine | Series A | $14.8M | 2026-07-27 | Weifang | Biotech |
| 28 | Elio Labs | Series A | $21.0M | 2026-07-23 | San Mateo | Artificial intelligence |
| 29 | Cooler Heads | Series A | $3.3M | 2026-07-23 | San Diego | Biotech |
| 30 | Transcripta Bio | Series A | $24.0M | 2026-07-22 | Palo Alto | Biotech |
| 31 | Yuannang Bio | Series A | $14.0M | 2026-07-22 | Hangzhou | Biotech |
| 32 | Tikva Allocell | Series A | $8.0M | 2026-07-22 | Singapore | Biotech |
| 33 | N-Zyme Biomedical | Series A | $4.6M | 2026-07-21 | Milwaukee | Biotech |
| 34 | Fibrox | Series A | $3.7M | 2026-07-21 | Pudong | Biotech |
| 35 | Brenus Pharma | Series A | $12.6M | 2026-07-20 | Issoire | Biotech |
| 36 | Deepin Technology | Series A | $14.1M | 2026-07-14 | Haidian | Artificial intelligence |
| 37 | Tianhu Technology | Series A | $29.0M | 2026-07-13 | Minhang | Artificial intelligence |
| 38 | ArcGen Bioscience | Series A | $6.7M | 2026-07-13 | Daejeon | Biotech |
| 39 | MingCeler | Series A | 2026-07-13 | Guangzhou | Biotech | |
| 40 | e-BLOT Life Sciences | Series A | 2026-07-13 | Pudong | Biotech | |
| 41 | Shenzhen Bay Island Cell Technology | Series A | $20.6M | 2026-07-10 | Biotech | |
| 42 | AlgaleX | Series A | $2.2M | 2026-07-10 | Uruma | Biotech |
| 43 | Alchemab Therapeutics | Series A | $33.6M | 2026-07-09 | London | Biotech |
| 44 | SynMetaBio | Series A | $14.7M | 2026-07-06 | Shanghai | Biotech |
| 45 | Insaifeiying | Series A | 2026-07-06 | Suzhou | Biotech | |
| 46 | Telum Therapeutics | Series A | $20.5M | 2026-07-01 | Noáin | Biotech |
| 47 | ZymeCO | Series A | $4.0M | 2026-07-01 | Monument | Biotech |
| 48 | Beeline Medicines | Series A | $126.3M | 2026-06-30 | Boston | Biotech |
| 49 | Xellar Biosystems | Series A | $29.5M | 2026-06-30 | Newton | Artificial intelligence |
| 50 | Prime Lifescience | Series A | $14.7M | 2026-06-30 | Hangzhou | Biotech |
| 51 | Lingtai Krypton Biotechnology | Series A | $13.7M | 2026-06-26 | Shuangliu | Biotech |
| 52 | RQ Bio | Series A | $112.5M | 2026-06-24 | London | Biotech |
| 53 | Anodyne Nanotech | Series A | $12.6M | 2026-06-24 | Boston | Biotech |
| 54 | NorthLinks Bio | Series A | $34.0M | 2026-06-23 | Boston | Biotech |
| 55 | Rapalogix Health | Series A | $20.0M | 2026-06-23 | Carlsbad | Biotech |
| 56 | Artivila Therapeutics | Series A | $14.7M | 2026-06-23 | Shenzhen | Artificial intelligence |
| 57 | Arrowsmith | Series A | $6.5M | 2026-06-22 | Ibaraki | Biotech |
| 58 | SyntaxBio | Series A | $14.4M | 2026-06-21 | Chicago | Biotech |
| 59 | Memento Medicines | Series A | $93.0M | 2026-06-18 | Chester | Biotech |
| 60 | MoleculeMind | Series A | $86.0M | 2026-06-17 | Haidian | Artificial intelligence |
| 61 | Vedana Therapeutics | Series A | $46.0M | 2026-06-17 | Seattle | Biotech |
| 62 | Spot Biosystems | Series A | $40.0M | 2026-06-17 | Palo Alto | Biotech |
| 63 | MultiValent Biotherapies | Series A | $27.4M | 2026-06-16 | Los Altos | Biotech |
| 64 | Aton Health | Series A | 2026-06-12 | Kansas City | Biotech | |
| 65 | Dioseve | Series A | $6.2M | 2026-06-11 | Tokyo | Biotech |
| 66 | Fesarius Therapeutics | Series A | $20.0M | 2026-06-10 | Brooklyn | Biotech |
| 67 | Qinghui Liannuo | Series A | $29.5M | 2026-06-09 | Beijing | Biotech |
| 68 | Antlia Bioscience | Series A | $6.0M | 2026-06-04 | Encinitas | Biotech |
| 69 | Apoha | Series A | $36.0M | 2026-06-03 | London | Biotech |
| 70 | Mammogen | Series A | $30.0M | 2026-06-03 | Aliso Viejo | Biotech |
| 71 | Tavo Biotherapeutics | Series A | $17.0M | 2026-06-02 | Dorchester | Biotech |
| 72 | IMU Biosciences | Series A | $38.4M | 2026-06-01 | London | Biotech |
| 73 | Oak hill bio | Series A | $32.5M | 2026-06-01 | Altrincham | Biotech |
| 74 | Countable Labs | Series A | $26.0M | 2026-05-28 | Palo Alto | Biotech |
| 75 | Secretome Therapeutics | Series A | $30.0M | 2026-05-27 | Dallas | Biotech |
| 76 | Ember LifeSciences | Series A | $20.9M | 2026-05-27 | Los Angeles | Biotech |
| 77 | Waypoint Bio | Series A | $20.0M | 2026-05-27 | New York | Artificial intelligence |
| 78 | Zhenyu Bio | Series A | $14.7M | 2026-05-27 | Chengdu | Biotech |
| 79 | SPERIKON | Series A | $14.7M | 2026-05-24 | Luzhou | Biotech |
| 80 | Bodie Hekang | Series A | 2026-05-21 | Shaoxing | Biotech | |
| 81 | Topwell Biotech | Series A | 2026-05-21 | Yanqing | Biotech | |
| 82 | cAMPfield Therapeutics | Series A | $180.0M | 2026-05-20 | San Diego | Biotech |
| 83 | Oorja Bio | Series A | $30.0M | 2026-05-19 | Houston | Biotech |
| 84 | PEEL Therapeutics | Series A | $20.0M | 2026-05-19 | Salt Lake City | Biotech |
| 85 | Degron Therapeutics | Series A | $40.0M | 2026-05-14 | Shanghai | Biotech |
| 86 | Immunocan | Series A | $36.8M | 2026-05-13 | Shanghai | Biotech |
| 87 | Sonomind | Series A | $23.5M | 2026-05-12 | Paris | Biotech |
| 88 | SuperMeat | Series A | $6.0M | 2026-05-12 | Tel Aviv | Biotech |
| 89 | Plastic New Technology | Series A | 2026-05-11 | Beijing | Biotech | |
| 90 | Hechen Biology | Series A | $14.7M | 2026-05-07 | Hefei | Biotech |
| 91 | Qihe Biotech | Series A | $14.7M | 2026-05-06 | Suzhou | Biotech |
| 92 | Shanmu SHANMU | Series A | $14.7M | 2026-05-06 | Shenzhen | Artificial intelligence |
| 93 | Beixcell | Series A | 2026-05-06 | Changping | Biotech | |
| 94 | Cytospire Therapeutics | Series A | $82.6M | 2026-05-05 | Altrincham | Biotech |
| 95 | Kanvas Biosciences | Series A | $48.0M | 2026-05-05 | Monmouth Junction | Biotech |
| 96 | Pumpkinseed Technologies | Series A | $20.0M | 2026-05-05 | Palo Alto | Biotech |
| 97 | Dandelion Health AI | Series A | $14.0M | 2026-05-05 | New York | Artificial intelligence |
| 98 | Latus Bio | Series A | $43.0M | 2026-05-04 | Philadelphia | Biotech |
| 99 | Moleculent | Series A | $20.0M | 2026-04-30 | Solna | Biotech |
| 100 | Sanyan Biotechnology | Series A | $1.5M | 2026-04-30 | Hangzhou | Biotech |
Table 1. The 100 most recent rounds. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,362.
Largest rounds
Largest round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Altos Labs | Series A | $3.0B | 2021-09-06 | San Francisco | Biotech |
| 2 | Xaira Therapeutics | Series A | $1.0B | 2024-04-23 | South San Francisco | Artificial intelligence |
| 3 | Verdiva Bio | Series A | $411.0M | 2025-01-09 | London | Biotech |
| 4 | LianBio | Series A | $310.0M | 2020-10-29 | Shanghai | Biotech |
| 5 | Uniquity Bio | Series A | $300.0M | 2024-05-15 | Malvern | Biotech |
| 6 | ReNAgade Therapeutics | Series A | $300.0M | 2023-05-23 | Cambridge | Biotech |
| 7 | Mabwell Biotech | Series A | $278.5M | 2020-04-29 | Shanghai | Biotech |
| 8 | Orbital Therapeutics | Series A | $270.0M | 2023-04-26 | Cambridge | Biotech |
| 9 | NantOmics | Series A | $250.8M | 2015-06-01 | Culver City | Biotech |
| 10 | Anthos Therapeutics | Series A | $250.0M | 2019-02-27 | Cambridge | Biotech |
| 11 | Aiolos Bio | Series A | $245.0M | 2023-10-24 | San Francisco | Biotech |
| 12 | Adrestia Therapeutics | Series A | $232.6M | 2020-12-18 | Babraham | Biotech |
| 13 | BlueRock Therapeutics | Series A | $225.0M | 2016-12-12 | Toronto | Biotech |
| 14 | Dispatch Bio | Series A | $216.0M | 2025-07-23 | Philadelphia | Biotech |
| 15 | Tome Biosciences | Series A | $213.0M | 2023-12-12 | Watertown | Biotech |
| 16 | AirNexis Therapeutics | Series A | $200.0M | 2026-01-09 | Palo Alto | Biotech |
| 17 | Treeline Biosciences | Series A | $200.0M | 2025-09-03 | Watertown | Biotech |
| 18 | Tenvie Therapeutics | Series A | $200.0M | 2025-01-08 | South San Francisco | Biotech |
| 19 | Soufflé Therapeutics | Series A | $200.0M | 2025-01-01 | Watertown | Biotech |
| 20 | Esco Lifesciences | Series A | $200.0M | 2021-05-26 | Singapore | Biotech |
| 21 | Alveus Therapeutics | Series A | $197.0M | 2026-01-08 | Philadelphia | Biotech |
| 22 | Callio Therapeutics | Series A | $187.0M | 2025-03-03 | Seattle | Biotech |
| 23 | Braveheart Bio | Series A | $185.0M | 2025-11-05 | San Francisco | Biotech |
| 24 | cAMPfield Therapeutics | Series A | $180.0M | 2026-05-20 | San Diego | Biotech |
| 25 | Timberlyne Therapeutics | Series A | $180.0M | 2025-01-09 | San Diego | Biotech |
| 26 | Antares Therapeutics | Series A | $177.0M | 2025-05-15 | Boston | Biotech |
| 27 | Allist Pharmaceuticals | Series A | $173.9M | 2019-05-24 | Shanghai | Biotech |
| 28 | GentiBio | Series A | $157.0M | 2021-08-11 | Seattle | Biotech |
| 29 | Korsana Biosciences | Series A | $150.0M | 2025-09-01 | Waltham | Biotech |
| 30 | Clasp Therapeutics | Series A | $150.0M | 2024-03-20 | Cambridge | Biotech |
| 31 | MasterControl | Series A | $150.0M | 2022-12-15 | Salt Lake City | Biotech |
| 32 | Curon Biopharma | Series A | $150.0M | 2018-07-30 | Shanghai | Biotech |
| 33 | Bitterroot Bio | Series A | $145.0M | 2023-06-07 | Palo Alto | Biotech |
| 34 | Doma Biopharmaceutical | Series A | $142.1M | 2022-06-01 | Suzhou | Biotech |
| 35 | Yufunian | Series A | $141.4M | 2023-05-29 | Dali | Biotech |
| 36 | Ottimo Pharma | Series A | $140.0M | 2024-12-19 | Sandwich | Biotech |
| 37 | VectorY | Series A | $138.0M | 2023-11-13 | Amsterdam | Biotech |
| 38 | Serapha Bio | Series A | $138.0M | 2026-01-01 | New York | Biotech |
| 39 | Reunion Neuroscience | Series A | $133.0M | 2025-09-16 | Toronto | Biotech |
| 40 | Slate Medicines | Series A | $130.0M | 2026-02-24 | Raleigh | Biotech |
| 41 | Beeline Medicines | Series A | $126.3M | 2026-06-30 | Boston | Biotech |
| 42 | Coultreon Biopharma | Series A | $125.0M | 2026-04-28 | Heverlee | Biotech |
| 43 | Ambros Therapeutics | Series A | $125.0M | 2025-12-16 | Irvine | Biotech |
| 44 | Adcytherix | Series A | $122.8M | 2025-10-16 | Marseille | Biotech |
| 45 | NGM Biopharmaceuticals | Series A | $122.0M | 2024-07-17 | South San Francisco | Biotech |
| 46 | Merida Biosciences | Series A | $121.0M | 2025-04-08 | Cambridge | Biotech |
| 47 | Solve Therapeutics | Series A | $120.0M | 2025-11-17 | Belmont | Biotech |
| 48 | Ouro Medicines | Series A | $120.0M | 2025-01-10 | San Francisco | Biotech |
| 49 | Cellular Biomedicine Group | Series A | $120.0M | 2021-09-28 | Palo Alto | Biotech |
| 50 | Myricx Bio | Series A | $115.3M | 2024-07-08 | London | Biotech |
| 51 | Axonis Therapeutics | Series A | $115.0M | 2024-10-30 | Boston | Biotech |
| 52 | RQ Bio | Series A | $112.5M | 2026-06-24 | London | Biotech |
| 53 | Kynexis | Series A | $112.3M | 2026-08-19 | Naarden | Biotech |
| 54 | Syncromune | Series A | $111.8M | 2024-12-20 | Fort Lauderdale | Biotech |
| 55 | Zephyr AI | Series A | $111.0M | 2024-03-13 | Fairfax Station | Artificial intelligence |
| 56 | RayThera | Series A | $110.0M | 2025-04-04 | San Diego | Biotech |
| 57 | Neogene Therapeutics | Series A | $110.0M | 2020-09-14 | Amsterdam | Biotech |
| 58 | Sidera Bio | Series A | $109.0M | 2025-12-09 | Copenhagen | Biotech |
| 59 | AavantiBio | Series A | $107.0M | 2020-10-22 | Cambridge | Biotech |
| 60 | Tortugas Neuroscience | Series A | $106.0M | 2026-04-21 | Framingham | Biotech |
| 61 | Synnovation Therapeutics | Series A | $102.0M | 2023-12-14 | Wilmington | Biotech |
| 62 | NILO Therapeutics | Series A | $101.0M | 2025-10-08 | New York | Biotech |
| 63 | Trace Neuroscience | Series A | $101.0M | 2024-11-12 | South San Francisco | Biotech |
| 64 | Stipple Bio | Series A | $100.0M | 2026-04-06 | Cambridge | Biotech |
| 65 | Addition Therapeutics | Series A | $100.0M | 2025-12-17 | South San Francisco | Biotech |
| 66 | Nudge | Series A | $100.0M | 2025-07-22 | San Francisco | Biotech |
| 67 | OTR Therapeutics | Series A | $100.0M | 2025-06-01 | Shanghai | Biotech |
| 68 | Navigator Medicines | Series A | $100.0M | 2024-08-27 | Scotch Plains | Biotech |
| 69 | OnCusp Therapeutics | Series A | $100.0M | 2024-01-04 | New York | Biotech |
| 70 | Inceptive | Series A | $100.0M | 2023-09-07 | Palo Alto | Biotech |
| 71 | Paratus Sciences | Series A | $100.0M | 2023-02-27 | New York | Biotech |
| 72 | Reistone Biopharma | Series A | $100.0M | 2022-05-09 | Pudong | Biotech |
| 73 | Tichuang Biotechnology | Series A | $100.0M | 2022-03-14 | Guangzhou | Biotech |
| 74 | Rectify Pharmaceuticals | Series A | $100.0M | 2021-10-14 | Cambridge | Biotech |
| 75 | Dyno Therapeutics | Series A | $100.0M | 2021-05-06 | Cambridge | Artificial intelligence |
| 76 | Joyn Bio | Series A | $100.0M | 2017-09-14 | Boston | Biotech |
| 77 | Emergence Therapeutics | Series A | $98.1M | 2021-12-07 | Duisburg | Biotech |
| 78 | NanoPhoria | Series A | $97.8M | 2025-10-06 | Milan | Biotech |
| 79 | Cajal Neuroscience | Series A | $96.0M | 2022-11-29 | Seattle | Biotech |
| 80 | Trogenix | Series A | $94.1M | 2025-10-06 | Edinburgh | Biotech |
| 81 | Firefly Bio | Series A | $94.0M | 2024-02-15 | San Francisco | Biotech |
| 82 | Newleos Therapeutics | Series A | $93.5M | 2025-02-13 | Boston | Biotech |
| 83 | Memento Medicines | Series A | $93.0M | 2026-06-18 | Chester | Biotech |
| 84 | Kivu Bioscience | Series A | $92.0M | 2024-10-28 | San Francisco | Biotech |
| 85 | Bambusa Therapeutics | Series A | $90.0M | 2025-11-17 | Boston | Biotech |
| 86 | Nested Therapeutics | Series A | $90.0M | 2022-10-06 | Cambridge | Biotech |
| 87 | Turing Pharmaceuticals | Series A | $90.0M | 2015-08-10 | New York | Biotech |
| 88 | Mnemo Therapeutics | Series A | $90.0M | 2021-06-16 | Paris | Biotech |
| 89 | Immutrin | Series A | $87.1M | 2026-03-24 | Cambridge | Biotech |
| 90 | Clade Therapeutics | Series A | $87.0M | 2021-11-03 | Cambridge | Biotech |
| 91 | MoleculeMind | Series A | $86.0M | 2026-06-17 | Haidian | Artificial intelligence |
| 92 | Rhygaze | Series A | $86.0M | 2025-01-10 | Basel | Biotech |
| 93 | Bioleum | Series A | $85.0M | 2025-05-22 | Oklahoma City | Biotech |
| 94 | Stylus Medicine | Series A | $85.0M | 2025-05-12 | Cambridge | Biotech |
| 95 | Rampart Bioscience | Series A | $85.0M | 2023-10-24 | La Jolla | Biotech |
| 96 | Epirium Bio | Series A | $85.0M | 2019-12-18 | San Diego | Biotech |
| 97 | Averna Therapeutics | Series A | $85.0M | 2024-06-25 | Boston | Biotech |
| 98 | Fosun Kite Biotechnology | Series A | $84.2M | 2025-10-17 | Shanghai | Biotech |
| 99 | Antag Therapeutics | Series A | $84.1M | 2024-12-04 | Copenhagen | Biotech |
| 100 | Augustine Therapeutics | Series A | $83.9M | 2025-03-24 | Leuven | Biotech |
Table 2. The 100 largest rounds. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,362.
By month
| Month | Companies |
|---|---|
| 2024-09 | 21 |
| 2024-10 | 26 |
| 2024-11 | 24 |
| 2024-12 | 31 |
| 2025-01 | 33 |
| 2025-02 | 16 |
| 2025-03 | 18 |
| 2025-04 | 14 |
| 2025-05 | 17 |
| 2025-06 | 25 |
| 2025-07 | 22 |
| 2025-08 | 22 |
| 2025-09 | 34 |
| 2025-10 | 29 |
| 2025-11 | 32 |
| 2025-12 | 44 |
| 2026-01 | 46 |
| 2026-02 | 23 |
| 2026-03 | 29 |
| 2026-04 | 19 |
| 2026-05 | 25 |
| 2026-06 | 26 |
| 2026-07 | 27 |
| 2026-08 | 20 |
Table 3. Biotech startups that raised Series A by month of the round. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,362.
Country
| Country | Companies |
|---|---|
| United States | 1,051 |
| China | 486 |
| United Kingdom | 132 |
| South Korea | 83 |
| France | 75 |
| Germany | 58 |
| Switzerland | 56 |
| Israel | 42 |
| Japan | 42 |
| Canada | 41 |
| The Netherlands | 29 |
| Singapore | 24 |
| Belgium | 23 |
| Denmark | 21 |
| Italy | 17 |
Table 4. Biotech startups that raised Series A by country. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,362.
City
| City | Companies |
|---|---|
| Cambridge | 88 |
| Shanghai | 79 |
| San Francisco | 75 |
| New York | 67 |
| San Diego | 60 |
| Boston | 56 |
| London | 47 |
| Hangzhou | 36 |
| Beijing | 35 |
| Shenzhen | 34 |
| Palo Alto | 33 |
| Suzhou | 32 |
| Paris | 30 |
| Seoul | 30 |
| Nanjing | 23 |
Table 5. Biotech startups that raised Series A by city. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,362.
Sector
| Sector | Companies |
|---|---|
| Biotech | 2,362 |
| Health care | 1,914 |
| Software | 273 |
| Artificial intelligence | 163 |
| Hardware | 84 |
| Cybersecurity | 24 |
| Energy | 19 |
| Fintech | 14 |
| Education | 12 |
| Commerce | 9 |
Table 6. Biotech startups that raised Series A by sector. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,362.
Biotech at other stages
Other sectors that raised Series A
software startups that raised Series A13,389
health care startups that raised Series A5,277
AI startups that raised Series A4,006
fintech startups that raised Series A3,577
commerce startups that raised Series A3,637
hardware startups that raised Series A4,426
education startups that raised Series A1,275
cybersecurity startups that raised Series A1,149
energy startups that raised Series A1,021
Cite: FundingWatcher, 2,362 biotech companies whose most recent round is Series A, 4 September 2026. https://fundingwatcher.com/startups/biotech/series-a/